Versor Investments’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-212,421
Closed -$5.71M 779
2025
Q3
$5.71M Buy
+212,421
New +$5.06M 1.05% 13
2024
Q4
Sell
-16,400
Closed -$609K 973
2024
Q3
$609K Buy
16,400
+8,142
+99% +$304K 0.1% 357
2024
Q2
$393K Buy
+8,258
New +$362K 0.07% 426
2022
Q4
Sell
-4,308
Closed -$304K 959
2022
Q3
$304K Buy
+4,308
New +$369K 0.02% 604
2021
Q3
Sell
-2,112
Closed -$322K 572
2021
Q2
$322K Buy
+2,112
New +$278K 0.01% 223

Other funds holding STAA

Versor Investments's STAA Position: Q4 2025 in Review

Versor Investments sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 212,421 shares — an estimated $5.71M sold.

Versor Investments first reported a position in STAA in Q2 2021 and held it in 5 quarters. The position peaked at $5.71M in Q3 2025. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • Versor Investments reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 212,421 STAAR Surgical shares in Q4 2025, an estimated $5.71M.
  • Versor Investments first reported a position in STAAR Surgical in Q2 2021 and held it in 5 quarters.
  • Versor Investments's STAAR Surgical position peaked at $5.71M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.